000 01241 a2200385 4500
005 20250513151034.0
264 0 _c19980908
008 199809s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.51.2.390
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChang, M H
245 0 0 _aOral drug of choice in carpal tunnel syndrome.
_h[electronic resource]
260 _bNeurology
_cAug 1998
300 _a390-3 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xtherapeutic use
650 0 4 _aCarpal Tunnel Syndrome
_xdrug therapy
650 0 4 _aDemography
650 0 4 _aDiuretics
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
700 1 _aChiang, H T
700 1 _aLee, S S
700 1 _aGer, L P
700 1 _aLo, Y K
773 0 _tNeurology
_gvol. 51
_gno. 2
_gp. 390-3
856 4 0 _uhttps://doi.org/10.1212/wnl.51.2.390
_zAvailable from publisher's website
999 _c9675595
_d9675595